Encouraging news. Important points: - No mo
Post# of 148175
(Total Views: 835)
Posted On: 10/20/2020 6:12:54 AM
Encouraging news.
Important points:
- No modification regarding sample size or endpoints
- Incorporation of another interim analysis at 75% or 293 patients (which to me suggests they see a good chance to stop the trial then!)
- Current enrollment: 230 patients; company will try everything to reach 293 patients in 4-6 weeks.
- UK sites will come online the next days
Important points:
- No modification regarding sample size or endpoints
- Incorporation of another interim analysis at 75% or 293 patients (which to me suggests they see a good chance to stop the trial then!)
- Current enrollment: 230 patients; company will try everything to reach 293 patients in 4-6 weeks.
- UK sites will come online the next days
(11)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼